Skip to main content

Table 1 Treatment used in groups of canine cardiac patients (ISACHC I–III)

From: Systemic inflammation in dogs with advanced-stage heart failure

Therapeutics ISACHC I (N = 10) (n) ISACHC II (N = 26) (n) ISACHC III (N = 26) (n)
Salbutemol 1   
Furosemide   26 21
ACE inhibitor   26 13
Pimobendan 1 15 14
Atenolol (beta-blocker)   2 4
Digoxin   5 9
Diltiazem (calcium-channel blocker)   4 4
Spironolactone   4 1
Potassium chloride   5  
Total number of dogs with therapy 2 26 21
  1. ISACHC International Small Animal Cardiac Health Council; N number of dogs included in ISACHC group; n number of dogs per ISACHC group receiving specific cardiac drug; ACE angiotensin-converting enzyme